Nephrolithiasis is common, affecting up to 10% of the population. Symptomatic stone episodes produce significant pain and suffering, as well as great individual and societal economic costs. Much effort has been directed towards understanding metabolic abnormalities that can increase urinary supersaturation, which is clearly one key factor that initiates and favors stone growth. However, crystal-crystal and crystal-cell interactions also appear to be critical events during the early stages of stone formation. Therefore, increased understanding of the factors that modulate the interface of urinary proteins and crystals, and hence their subsequent interaction with other crystals or cells, is a necessary prerequisite for identifying new therapeutic targets. Such knowledge will in turn enable development of new strategies for the treatment and prevention of renal stone disease. Therefore, the urinary phenotyping core will serve 4 key functions in support of this Urology O'Brien Center: 1) Quantification of urinary components of the supersaturation profile 2) Quantification of urinary inhibitor activity 3) Renal biopsy processing, including staining of sections, and quantification of calcifications 3) Biobanking of urine, blood, renal tissues, and stones The Urinary Phenotyping Core will directly support Projects 2 and 3, and it will likely be of value for pilot projects initiated during the Center's activities that require biobanked samples or urinary assays.

Public Health Relevance

The Urinary Phenotyping Core will coordinate measurement of all urine parameters that influence kidney stone formation including supersaturation profiles, quantitative crystallization assays, and maintain the biobank of these fully phenotyped patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54DK100227-01
Application #
8626073
Study Section
Special Emphasis Panel (ZDK1-GRB-9 (M2))
Project Start
Project End
Budget Start
2013-09-29
Budget End
2014-06-30
Support Year
1
Fiscal Year
2013
Total Cost
$281,628
Indirect Cost
$52,283
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Rule, Andrew D; Kremers, Walter K (2016) What Is the Correct Approach for Comparing GFR by Different Methods across Levels of GFR? Clin J Am Soc Nephrol 11:1518-21
Leng, Shuai; Huang, Alice; Cardona, Juan Montoya et al. (2016) Dual-Energy CT for Quantification of Urinary Stone Composition in Mixed Stones: A Phantom Study. AJR Am J Roentgenol 207:321-9
Perinpam, Majuran; Ware, Erin B; Smith, Jennifer A et al. (2016) Key influence of sex on urine volume and osmolality. Biol Sex Differ 7:12
Jaeger, Christopher D; Rule, Andrew D; Mehta, Ramila A et al. (2016) Endoscopic and Pathologic Characterization of Papillary Architecture in Struvite Stone Formers. Urology 90:39-44
Landry, Greg M; Hirata, Taku; Anderson, Jacob B et al. (2016) Sulfate and thiosulfate inhibit oxalate transport via a dPrestin (Slc26a6)-dependent mechanism in an insect model of calcium oxalate nephrolithiasis. Am J Physiol Renal Physiol 310:F152-9
Haley, William E; Enders, Felicity T; Vaughan, Lisa E et al. (2016) Kidney Function After the First Kidney Stone Event. Mayo Clin Proc 91:1744-1752
Giesen, Callen; Lieske, John C (2016) The Influence of Processing and Storage Conditions on Renal Protein Biomarkers. Clin J Am Soc Nephrol :
Ferrero, Andrea; Montoya, Juan C; Vaughan, Lisa E et al. (2016) Quantitative Prediction of Stone Fragility From Routine Dual Energy CT: Ex vivo proof of Feasibility. Acad Radiol 23:1545-1552
Lieske, John C; Turner, Stephen T; Edeh, Samuel N et al. (2016) Heritability of dietary traits that contribute to nephrolithiasis in a cohort of adult sibships. J Nephrol 29:45-51
Cheungpasitporn, Wisit; Rossetti, Sandro; Friend, Keith et al. (2016) Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis. J Nephrol 29:211-9

Showing the most recent 10 out of 51 publications